Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 8/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.45 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.45 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | DRD1 | P21728 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3844808 | 0.85 | FTO (0.34) | FTOMEN1MAPTKMT2AHPGD | |
| SCHEMBL19472010 | 0.79 | TYMS (0.37) | MEN1MAPTKMT2ATDP1ALDH1A1 | |
| SCHEMBL3705213 | 0.75 | FTO (0.44) | FTOMEN1MAPTKMT2AHPGD | |
| SCHEMBL12986496 | 0.74 | FTO (0.43) | FTOMEN1MAPTKMT2AHPGD | |
| SCHEMBL5088010 | 0.71 | FTO (0.39) | FTOMEN1MAPTKMT2AHPGD | |
| SCHEMBL4344779 | 0.71 | FTO (0.38) | FTOMEN1MAPTKMT2AHPGD | |
| SCHEMBL27833470 | 0.65 | FTO (0.83) | FTOMEN1MAPTKMT2AHPGD | |
| SCHEMBL23460332 | 0.64 | FTO (0.55) | FTOMEN1MAPTKMT2AHPGD | |
| SCHEMBL1539098 | 0.64 | FTO (0.81) | FTOMEN1MAPTKMT2AHPGD | |
| SCHEMBL29919351 | 0.64 | FTO (0.55) | FTOMEN1MAPTKMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 650 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026098047-A1 | RADIOTHERAPY SYSTEM, AUXILIARY SYSTEM AND METHOD FOR ASSESSING FREE RADICAL DAMAGE, AND USES THEREOF | 迈胜医疗设备有限公司 | 2026-05-15 | — | — | WO | claimed |
| CN-119792773-A | Composite micro-guide wire and manufacturing method thereof | 环心医疗科技(苏州)有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-118593077-A | Automatic implantation device for self-control thermotherapy magnetic hydrogel | 东南大学 | 2024-09-06 | — | — | CN | claimed |
| CN-118526262-A | Manual implantation device of automatic control thermotherapy magnetism hydrogel | 东南大学 | 2024-08-23 | — | — | CN | claimed |
| CN-118434765-A | BCMA monoclonal antibodies and antibody-drug conjugates | 杭州多禧生物科技有限公司 | 2024-08-02 | — | — | CN | claimed |
| CN-114617069-B | Functional bio-based cat litter capable of detecting diseases of cat urinary system | 中国科学院青岛生物能源与过程研究所 | 2023-03-24 | — | — | CN | claimed |
| CN-114617069-A | Functional bio-based cat litter capable of detecting diseases of cat urinary system | 中国科学院青岛生物能源与过程研究所 | 2022-06-14 | — | — | CN | claimed |
| EP-3551034-A1 | GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS | Progenity, Inc. (US) | 2019-10-16 | — | — | EP | claimed |
| CN-207708311-U | A kind of medical guiding wire and medical tubing | 北京灵泽医药技术开发有限公司 | 2018-08-10 | — | — | CN | claimed |
| WO-2018106933-A1 | GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS | PROGENITY INC. (US) | 2018-06-14 | — | — | WO | claimed |
| US-20110318273-A1 | FLUORESCENT CONTRAST AGENTS | GE HEALTHCARE AS (NO) | 2011-12-29 | — | — | US | claimed |
| US-20110053192-A1 | Method Of Rapid Detection Of An Analyte In Bodily Fluids Using A Fluorescent Dry Test Strip Biosensor | XU TOM CHENG | 2011-03-03 | — | — | US | claimed |
| US-20090238765-A1 | Fluorescent Contrast Agent | GE HEALTHCARE AS (NO) | 2009-09-24 | — | — | US | claimed |
| US-20090104635-A1 | Fluorescent Dry Test Strip Biosensor | SINOCARE (CN) | 2009-04-23 | — | — | US | claimed |
| EP-2025349-A2 | Fluorescent contrast agents | GE Healthcare AS (NO) | 2009-02-18 | — | — | EP | claimed |
| CN-101115507-A | Fluorescent contrast agents | AMERSHAM HEALTH AS (NO) | 2008-01-30 | — | — | CN | claimed |
| EP-1824522-A2 | FLUORESCENT CONTRAST AGENTS | GE Healthcare AS (NO) | 2007-08-29 | — | — | EP | claimed |
| WO-2006065146-A2 | FLUORESCENT CONTRAST AGENTS | GE HEALTHCARE AS (NO) | 2006-06-22 | — | — | WO | claimed |
| WO-2001080715-A2 | METHODS FOR IDENTIFYING COMPOUNDS USEFUL FOR PREVENTING ACUTE CLINICAL VASCULAR EVENTS IN A SUBJECT | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2001-11-01 | — | — | WO | claimed |
| US-4789638-A | COLORIMETRIC INDICATORS; AIR | KRAMER, N. DAVID | 1988-12-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090238765-A1 | Fluorescent Contrast Agent | MPO, FPR3, FPR1 | FTO 2362/4885MEN1 3484/4885MAPT 2318/4885 |
| US-20110318273-A1 | FLUORESCENT CONTRAST AGENTS | MPO, FPR3, FPR1 | FTO 2451/4885MEN1 3479/4885MAPT 2392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.